No Data
Jiangsu Apon Medical Technology Co., Ltd.'s (SZSE:300753) Shares Climb 43% But Its Business Is Yet to Catch Up
Jiangsu apon medical technology (300753.SZ): The anesthesia siasun robot&automation project is still in the design and development stage, without obtaining registration certification and not yet in production.
On December 6, Gelonghui reported that jiangsu apon medical technology (300753.SZ) stated on the investor interaction platform that the company's anesthesia robot project is still in the design and development stage, has not obtained registration certification and has not achieved production. This project has high technical requirements, and currently has met the preset parameter requirements in simulation tissues, with good accuracy and repeatability, and is further optimizing its performance in animal tissues. The project is progressing normally according to the company's project plan.
Here's What's Concerning About Jiangsu Apon Medical Technology's (SZSE:300753) Returns On Capital
Jiangsu Apon Medical Technology (300753.SZ): The company has officially joined the "brain-computer interface industry alliance" as one of its members.
Gelonghui, November 4th, jiangsu apon medical technology (300753.SZ) stated on the investor interaction platform that it will participate in the Second Brain-Computer Interface Conference and the Fourth Brain-Computer Interface Industry Alliance Conference, which will be held in wuhan, hubei on November 16th to 17th. The company has been invited to attend and has officially joined the "Brain-Computer Interface Industry Alliance" as one of its members. This conference, themed 'Brain-Machine Interconnection, Creating the Future Together,' aims to strengthen the exchange and cooperation between brain-computer interface technology and industry, discussing the future development of the brain-computer interface industry.
Aibang Healthcare: Third Quarter 2024 Report
Jiangsu Apon Medical Technology (300753.SZ): The net income in the first three quarters was 3.8073 million yuan, a year-on-year decrease of 43.99%.
On October 29, Gelonhui reported that Jiangsu Apon Medical Technology (300753.SZ) released its third quarter report for 2024, achieving revenue of 0.275 billion yuan in the first three quarters, down 7.12% year-on-year; net income attributable to shareholders of the listed company was 3.8073 million yuan, down 43.99% year-on-year; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 0.8721 million yuan, down 74.25% year-on-year; basic earnings per share was 0.0302 yuan.
Jiangsu Apon Medical Technology Co., Ltd. (SZSE:300753) Not Doing Enough For Some Investors As Its Shares Slump 25%
